Pro Clb Global Ltd

AGM details

• AGM held on 30 September 2026 at 04:00 PM via video conferencing/ OAVM.

Resolutions

• Adoption of audited financial statements for year ended 31 March 2026.
• Reappointment of Het Kalpeshkumar Shah by rotation.
• Appointment of Shweta Jain & Co LLP as Statutory Auditor till 37th AGM; remuneration to be fixed.
• Regularization of Satish Papnai as Independent Director.
• Appointment of Rohit Bhatia & Associates as Secretarial Auditor for five years.

Voting results

• All resolutions passed by requisite majority.

Dividend

• No dividend proposed or declared.

Directors & Auditors

• Director changes: Het Kalpeshkumar Shah reappointed; Satish Papnai regularized as Independent Director.
• Statutory auditor appointed: Shweta Jain & Co LLP from this AGM to 37th AGM; remuneration to be fixed.
• Secretarial auditor appointed: Rohit Bhatia & Associates for five years.

Material related party transactions

• No material RPTs disclosed in filing.

Other material approvals

• No other material approvals disclosed.

Pro CLB Global Ltd: Trading window closed from 1 October 2026 until 48 hours after the declaration of unaudited financial results for the quarter ended 30 September 2026

Resolutions and outcomes

• Resolution 1 (Special): Increase in Authorized Share Capital and alteration of MOA; passed 99.99% in favour.
• Resolution 2 (Special): Issuance of Convertible Warrants on a preferential basis; passed 99.99% in favour.
• Resolution 3 (Special): Authorize board to borrow money under Section 180(1)(C); passed 99.99% in favour.
• Resolution 4 (Special): Invest, lend, guarantee, and security beyond Section 186; passed 99.99% in favour.
• Record date 24-07-2026; total shareholders on record 1,805.

Beneficial owner update

• Corrigendum to the July 29, 2026 Postal Ballot Notice updates the identity of ultimate beneficial owners.
• Amends Explanatory Statement for Resolution No. 2; revisions relate to ownership identities of proposed allottees.
• The update lists post-shareholding details for each allottee, with Non-Promoter Category predominating.
• Notable large allotments include Mideast Healthcare Pvt Ltd: 700,000 shares, 4.19%.
• Rajnikant Chandulal Shukla HUF allotted 650,000 shares (3.89%).
• Neeta Mandevia: 527,950 shares, 3.16%.
• Sharat Kumar: 310,560 shares, 1.86%.
• Table includes numerous non-promoter natural persons and entities with precise post-shareholding.
• Original notice content remains unchanged except for these amendments.
• Read with the corrigendum and the original notice for full context.

Quarterly results snapshot

• Revenue from operations ₹29.58 lakh; total income ₹29.58 lakh for Q1 FY2026 (standalone).
• Expenses total ₹6.32 lakh; employee ₹2.10 lakh; other expenses ₹4.18 lakh; finance costs ₹0.04 lakh.
• Profit before tax ₹23.26 lakh; profit after tax ₹23.26 lakh; deferred tax credit ₹0.38 lakh.
• Earnings per share: basic ₹0.46; diluted ₹0.46; paid-up capital ₹510.30 lakh.
• Segment: Trading is the single reportable segment; auditor: unmodified opinion.

Standalone Q1 FY2026 results

• Standalone unaudited financial results for the quarter ended 30 June 2026 approved, with Limited Review Report.

Meeting Details

• Date: 12 August 2026; Location: 407 Orbit, Bodakdev, Ahmedabad-380054.
• Time of meeting not disclosed.

Key Agenda Items

• Unaudited standalone Q1 FY2026-27 results to be considered.
• Consideration under Regulation 33 of SEBI LODR, 2015.

Other Notes